Publications by authors named "Ramon Guardia"

Claim this Profile
M
Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis.
Rocío Parody, Isabel Sánchez-Ortega, Christelle Ferrá, Ramon Guardia, Carme Talarn

Oncol Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia.
Eulàlia Genescà, Mireia Morgades, Pau Montesinos, Pere Barba, Cristina Gil

Haematologica· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.
Jordi Ribera, Lurdes Zamora, Mireia Morgades, Susana Vives, Isabel Granada

Genes Chromosomes Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.
Pere Barba, Mireia Morgades, Pau Montesinos, Cristina Gil, María-Laura Fox, Ramon Guardia

Eur J Haematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia.
Josep-Maria Ribera, Mireia Morgades, Pau Montesinos, Rodrigo Martino, Pere Barba

Leuk Lymphoma· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Josep-Maria Ribera, Olga García, Cristina Gil, Santiago Mercadal, Irene García-Cadenas

Leuk Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine.
Marta Cabezón, Joan Bargay, Blanca Xicoy, Olga García, Josep Borrás

Oncotarget· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia.
Cristina Motlló, Josep-Maria Ribera, Mireia Morgades, Isabel Granada, Pau Montesinos

Leuk Lymphoma· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms.
Jordi Ribera, Lurdes Zamora, Mireia Morgades, Mar Mallo, Neus Solanes

Genes Chromosomes Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid.
Ricardo Sanchez, Rosa Ayala, Rafael Alberto Alonso, María Pilar Martínez, Jordi Ribera

Ann Hematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy.
Nicholas Kelleher, David Gallardo, José González-Campos, Jesús M Hernández-Rivas, Pau Montesinos

Leuk Lymphoma· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of transplant eligibility and availability of a human leukocyte antigen-identical matched related donor on outcome of older patients with acute lymphoblastic leukemia.
Pere Barba, Rodrigo Martino, David Martinez-Cuadron, García Olga, Albert Esquirol, Ramón Guardia

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and efficacy of outpatient therapy with intermediate dose cytarabine, fludarabine and idarubicin for patients with acute myeloid leukaemia aged 70 or older.
Susana Vives, Albert Oriol, Sònia Piernas, Salut Brunet, Victòria Clapés, Ramon Guardia

Eur J Haematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
Jordi Ribera, Mireia Morgades, Lurdes Zamora, Pau Montesinos, Inés Gómez-Seguí

Cancer· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study.
Gemma Osca-Gelis, Montserrat Puig-Vives, Marc Saez, David Gallardo, Natalia Lloveras

Leuk Lymphoma· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.
Josep-Maria Ribera, Albert Oriol, Mireia Morgades, Pau Montesinos, Josep Sarrà

J Clin Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobilization and engraftment of peripheral blood stem cells in healthy related donors >55 years old.
Cristina Motlló, Juan-Manuel Sancho, Joan-Ramon Grífols, Jordi Juncà, Mireia Morgades, Ramon Guardia

Cytotherapy· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy.
Marta Pratcorona, Salut Brunet, Josep Nomdedéu, Josep Maria Ribera, Mar Tormo

Blood· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors for poor peripheral blood stem cell mobilization and peak CD34(+) cell count to guide pre-emptive or immediate rescue mobilization.
Juan-Manuel Sancho, Mireia Morgades, Joan-Ramon Grifols, Jordi Juncà, Ramon Guardia

Cytotherapy· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.
Anna Bosch-Vizcaya, Arianne Pérez-García, Salut Brunet, Carlos Solano, Ismael Buño, Ramon Guardia

Biol Blood Marrow Transplant· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.
David Valcárcel, Pau Montesinos, Isabel Sánchez-Ortega, Salut Brunet, Jordi Esteve, Ramón Guardia

Cancer· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.
Javier de la Rubia, Federico Moscardó, María J Gómez, Ramón Guardia, Pilar Rodríguez

Transfus Apher Sci· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group.
Albert Oriol, Susana Vives, Jesús-María Hernández-Rivas, Mar Tormo, Inmaculada Heras, Ramon Guardia

Haematologica· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.
Mariano Monzo, Salut Brunet, Alvaro Urbano-Ispizua, Alfons Navarro, Granada Perea, Ramon Guardia

Blood· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
Salut Brunet, Jordi Esteve, Joan Berlanga, Josep M Ribera, Javier Bueno, Ramon Guardia

Haematologica· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis